For Approved Qualified Domestic Institutional Investors in China

Daniel Lyons, Ph.D., CFA

Portfolio Manager | Research Analyst
Daniel Lyons, Ph.D., CFA | Janus Henderson Investors

Daniel Lyons is a Portfolio Manager and Research Analyst on the Health Care and US Small/Mid-Cap Growth Teams at Janus Henderson Investors, a role he has held since 2018. Prior to this, he was a research analyst from 2000. He focuses on biotechnology and life science tools sectors for the Health Care Sector Research Team. Daniel started consulting for Janus in 1997 and joined the research team full time in 2000.

Daniel received his bachelor of arts degree in biochemistry and chemistry from Rice University, graduating magna cum laude. He also earned a PhD from Stanford University’s programme in immunology and conducted postdoctoral research with a Nobel Laureate at the University of Colorado. He holds the Chartered Financial Analyst designation and has 23 years of financial industry experience.

Products Managed

Articles Written

Hiding in plain sight: The investment case for healthcare
Timely & Topical

Hiding in plain sight: The investment case for healthcare

Why attractive valuations and new growth opportunities make healthcare worthy of another look by investors.

JH Explorer in San Diego: The future of treating diabetes
Timely & Topical

JH Explorer in San Diego: The future of treating diabetes

A new approach to treating diabetes could lead to weight loss and cardiovascular benefits, unlocking the potential for significant growth.

Investing through the ups and downs of biopharma research

Investing through the ups and downs of biopharma research

The biopharmaceutical industry often moves to the beat of its own drummer, creating opportunities for diversification.